US2012053295A1
|
|
Cationic poly (amino acids) and uses thereof
|
US2012046453A1
|
|
Protein charge regulator and protein-encapsulating polymer micelle complex
|
US2011110881A1
|
|
Liquid composition of cisplatin coordination compound
|
US2009258416A1
|
|
Polymer micelle complex including nucleic acid
|
US2009186076A1
|
|
Combined Use of TGF-Beta Signaling Inhibitor and Antitumor Agent
|
US2009081458A1
|
|
Electrostatically bonded polymer vesicle
|
WO2005080032A1
|
|
Process for producing iron colloid, and iron-colloid-bearing polymer micelle
|
JP2005280076A
|
|
Polymer composite
|
CA2454807A1
|
|
Cultured cell construct which contains spheroids of cultured animal cells and the use thereof
|
WO02056020A1
|
|
Complexes of solid with polymer for biological assay
|
AU1010002A
|
|
Polyoxyethylene having a sugar on one end and a different functional group on the other end, and a method for the production thereof
|
JP2003119229A
|
|
Crosslinked hydrogel derived from macromonomer having hydrophilic polymer chain
|
AU4265100A
|
|
Heterotelechelic block copolymers and process for preparing same
|
JP2001208754A
|
|
Composition for detecting biological specimen
|
JP2001131092A
|
|
Laminar structure for controlling passage of medicine
|
WO9957174A1
|
|
Polyoxyethylene derivatives having optionally protected amino group at one end and process for producing the same
|
JPH11322917A
|
|
Polyoxyethylene derivative having organic silylsulfide group on one terminal
|
JPH11322916A
|
|
Heterotelechelic polymer having biotin residue at one end
|
EP0921139A1
|
|
Modified polymers containing poly(2-hydroxyethyl (meth)acrylate) segment in the molecule
|
JPH10195152A
|
|
Core-shell microsphere and its production
|